Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

Affiliations

• ¹ Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ² Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
• ³ Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
• ⁴ Consultant in Obstetrics, Institute for Women's Health, University College London, UK.
• ⁵ Consultant Obstetrician, St Thomas' Hospital, London, UK.
• ⁶ Consultant in Obstetrics and Fetal Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
• ⁷ Division of Maternal-Fetal Medicine, Wayne State University, Detroit, MI, USA.
• ⁸ Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USA.
• ⁹ Consultant in Obstetrics and Subspecialist in Fetal Medicine, St George's University of London, London, UK.
• ¹⁰ Consultant in Obstetrics and Fetal Medicine, Norfolk and Norwich University Hospital, Norwich, UK.
• ¹¹ Consultant Obstetrician, Subspecialist in Maternal and Fetal Medicine, Barts Health NHS Trust, London, UK.
• ¹² Director of Scientific and Medical Affairs, Sanofi Pasteur, Swiftwater, PA, USA.
• ¹³ Professor of Fetal Medicine, Newcastle University, Newcastle upon Tyne, UK.
• ¹⁴ Deputy Director of Immunization Technical Support Unit, Public Health Fund of India, New Delhi, India.
• ¹⁵ Global Healthcare Consulting, New Delhi, India; Erasmus University Medical Center, Rotterdam, The Netherlands.
• ¹⁶ Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: [email protected].